With increasing availability and more diverse real-world data (RWD), pharmaceutical and medical device companies are recognizing the value of using the right data sets, asking the right questions, and engaging trusted partners to meet their business needs. Focused use of RWD throughout the product life cycle can help reveal critical insights needed to bring new treatments to market efficiently and effectively.
Learn more as data science and outcomes research professionals present novel solutions and case studies that demonstrate the value of employing a unified approach to evidence generation. Discover ways to amplify your evidence portfolio using retrospective and near-real-time global data, analytics, and services.
Visit our IBM MarketScan Research Database webpage to access more content.